SUPN 8-K 2026-11-02

SUPERNUS PHARMACEUTICALS, INC. (SUPN) 8-K dated 2026-11-02 — accession 0001104659-26-121103.

SUPERNUS PHARMACEUTICALS, INC. (SUPN) is a drug manufacturers - specialty & generic company listed on NASDAQ.

SUPERNUS PHARMACEUTICALS, INC. filed a 8-K on 2026-11-02. Accession 0001104659-26-121103.

This 8-K covers: Listing notice (Item 3.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported SUPN revenue for 2025-12-31 was $719.0M. Net income was -$38.5M. Revenue was up 8.6% from 2024-12-31 to 2025-12-31. SUPN currently screens at market cap $2.53B.

Not investment advice. The SUPN SEC hub lists recent forms. The stock page is the research view.